Global Dermatology OTC Medications Market Insights and Forecast to 2027

1 Study Coverage
    1.1 Dermatology OTC Medications Product Introduction
    1.2 Market by Type
        1.2.1 Global Dermatology OTC Medications Market Size Growth Rate by Type
        1.4.2 External Use
        1.4.3 Oral
    1.3 Market by Application
        1.3.1 Global Dermatology OTC Medications Market Size Growth Rate by Application
        1.3.2 Hospital
        1.3.3 Drug Store
        1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Dermatology OTC Medications Sales Estimates and Forecasts 2016-2027
    2.2 Global Dermatology OTC Medications Revenue Estimates and Forecasts 2016-2027
    2.3 Global Dermatology OTC Medications Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Dermatology OTC Medications Regions by Sales
        2.4.1 Global Top Dermatology OTC Medications Regions by Sales (2016-2021)
        2.4.2 Global Top Dermatology OTC Medications Regions by Sales (2022-2027)
    2.5 Global Top Dermatology OTC Medications Regions by Revenue
        2.5.1 Global Top Dermatology OTC Medications Regions by Revenue (2016-2021)
        2.5.2 Global Top Dermatology OTC Medications Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Dermatology OTC Medications Sales by Manufacturers
        3.1.1 Global Top Dermatology OTC Medications Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Dermatology OTC Medications Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Dermatology OTC Medications Sales in 2020
    3.2 Global Dermatology OTC Medications Revenue by Manufacturers
        3.2.1 Global Top Dermatology OTC Medications Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Dermatology OTC Medications Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Dermatology OTC Medications Revenue in 2020
    3.3 Global Dermatology OTC Medications Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Dermatology OTC Medications Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Dermatology OTC Medications Sales by Type
        4.1.1 Global Dermatology OTC Medications Historical Sales by Type (2016-2021)
        4.1.2 Global Dermatology OTC Medications Forecasted Sales by Type (2022-2027)
        4.1.3 Global Dermatology OTC Medications Sales Market Share by Type (2016-2027)
    4.2 Global Dermatology OTC Medications Revenue by Type
        4.2.1 Global Dermatology OTC Medications Historical Revenue by Type (2016-2021)
        4.2.2 Global Dermatology OTC Medications Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Dermatology OTC Medications Revenue Market Share by Type (2016-2027)
    4.3 Global Dermatology OTC Medications Price by Type
        4.3.1 Global Dermatology OTC Medications Price by Type (2016-2021)
        4.3.2 Global Dermatology OTC Medications Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Dermatology OTC Medications Sales by Application
        5.1.1 Global Dermatology OTC Medications Historical Sales by Application (2016-2021)
        5.1.2 Global Dermatology OTC Medications Forecasted Sales by Application (2022-2027)
        5.1.3 Global Dermatology OTC Medications Sales Market Share by Application (2016-2027)
    5.2 Global Dermatology OTC Medications Revenue by Application
        5.2.1 Global Dermatology OTC Medications Historical Revenue by Application (2016-2021)
        5.2.2 Global Dermatology OTC Medications Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Dermatology OTC Medications Revenue Market Share by Application (2016-2027)
    5.3 Global Dermatology OTC Medications Price by Application
        5.3.1 Global Dermatology OTC Medications Price by Application (2016-2021)
        5.3.2 Global Dermatology OTC Medications Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Dermatology OTC Medications Market Size by Type
        6.1.1 North America Dermatology OTC Medications Sales by Type (2016-2027)
        6.1.2 North America Dermatology OTC Medications Revenue by Type (2016-2027)
    6.2 North America Dermatology OTC Medications Market Size by Application
        6.2.1 North America Dermatology OTC Medications Sales by Application (2016-2027)
        6.2.2 North America Dermatology OTC Medications Revenue by Application (2016-2027)
    6.3 North America Dermatology OTC Medications Market Size by Country
        6.3.1 North America Dermatology OTC Medications Sales by Country (2016-2027)
        6.3.2 North America Dermatology OTC Medications Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Dermatology OTC Medications Market Size by Type
        7.1.1 Europe Dermatology OTC Medications Sales by Type (2017-2027)
        7.1.2 Europe Dermatology OTC Medications Revenue by Type (2017-2027)
    7.2 Europe Dermatology OTC Medications Market Size by Application
        7.2.1 Europe Dermatology OTC Medications Sales by Application (2017-2027)
        7.2.2 Europe Dermatology OTC Medications Revenue by Application (2017-2027)
    7.3 Europe Dermatology OTC Medications Market Size by Country
        7.3.1 Europe Dermatology OTC Medications Sales by Country (2017-2027)
        7.3.2 Europe Dermatology OTC Medications Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Dermatology OTC Medications Market Size by Type
        8.1.1 Asia Pacific Dermatology OTC Medications Sales by Type (2018-2027)
        8.1.2 Asia Pacific Dermatology OTC Medications Revenue by Type (2018-2027)
    8.2 Asia Pacific Dermatology OTC Medications Market Size by Application
        8.2.1 Asia Pacific Dermatology OTC Medications Sales by Application (2018-2027)
        8.2.2 Asia Pacific Dermatology OTC Medications Revenue by Application (2018-2027)
    8.3 Asia Pacific Dermatology OTC Medications Market Size by Region
        8.3.1 Asia Pacific Dermatology OTC Medications Sales by Region (2018-2027)
        8.3.2 Asia Pacific Dermatology OTC Medications Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Dermatology OTC Medications Market Size by Type
        9.1.1 Latin America Dermatology OTC Medications Sales by Type (2019-2027)
        9.1.2 Latin America Dermatology OTC Medications Revenue by Type (2019-2027)
    9.2 Latin America Dermatology OTC Medications Market Size by Application
        9.2.1 Latin America Dermatology OTC Medications Sales by Application (2019-2027)
        9.2.2 Latin America Dermatology OTC Medications Revenue by Application (2019-2027)
    9.3 Latin America Dermatology OTC Medications Market Size by Country
        9.3.1 Latin America Dermatology OTC Medications Sales by Country (2019-2027)
        9.3.2 Latin America Dermatology OTC Medications Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Dermatology OTC Medications Market Size by Type
        6.1.1 Middle East and Africa Dermatology OTC Medications Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Dermatology OTC Medications Revenue by Type (2016-2027)
    6.2 Middle East and Africa Dermatology OTC Medications Market Size by Application
        6.2.1 Middle East and Africa Dermatology OTC Medications Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Dermatology OTC Medications Revenue by Application (2016-2027)
    6.3 Middle East and Africa Dermatology OTC Medications Market Size by Country
        6.3.1 Middle East and Africa Dermatology OTC Medications Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Dermatology OTC Medications Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 Bayer
        11.1.1 Bayer Corporation Information
        11.1.2 Bayer Overview
        11.1.3 Bayer Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Bayer Dermatology OTC Medications Product Description
        11.1.5 Bayer Related Developments
    11.2 GSK
        11.2.1 GSK Corporation Information
        11.2.2 GSK Overview
        11.2.3 GSK Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 GSK Dermatology OTC Medications Product Description
        11.2.5 GSK Related Developments
    11.3 Teva
        11.3.1 Teva Corporation Information
        11.3.2 Teva Overview
        11.3.3 Teva Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Teva Dermatology OTC Medications Product Description
        11.3.5 Teva Related Developments
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Corporation Information
        11.4.2 Johnson & Johnson Overview
        11.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Johnson & Johnson Dermatology OTC Medications Product Description
        11.4.5 Johnson & Johnson Related Developments
    11.5 Novartis
        11.5.1 Novartis Corporation Information
        11.5.2 Novartis Overview
        11.5.3 Novartis Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Novartis Dermatology OTC Medications Product Description
        11.5.5 Novartis Related Developments
    11.6 Mylan
        11.6.1 Mylan Corporation Information
        11.6.2 Mylan Overview
        11.6.3 Mylan Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Mylan Dermatology OTC Medications Product Description
        11.6.5 Mylan Related Developments
    11.7 Sun Pharmaceutical
        11.7.1 Sun Pharmaceutical Corporation Information
        11.7.2 Sun Pharmaceutical Overview
        11.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Sun Pharmaceutical Dermatology OTC Medications Product Description
        11.7.5 Sun Pharmaceutical Related Developments
    11.8 Aurobindo
        11.8.1 Aurobindo Corporation Information
        11.8.2 Aurobindo Overview
        11.8.3 Aurobindo Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Aurobindo Dermatology OTC Medications Product Description
        11.8.5 Aurobindo Related Developments
    11.9 Galderma
        11.9.1 Galderma Corporation Information
        11.9.2 Galderma Overview
        11.9.3 Galderma Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 Galderma Dermatology OTC Medications Product Description
        11.9.5 Galderma Related Developments
    11.10 CR SANJIU
        11.10.1 CR SANJIU Corporation Information
        11.10.2 CR SANJIU Overview
        11.10.3 CR SANJIU Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 CR SANJIU Dermatology OTC Medications Product Description
        11.10.5 CR SANJIU Related Developments
    11.1 Bayer
        11.1.1 Bayer Corporation Information
        11.1.2 Bayer Overview
        11.1.3 Bayer Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Bayer Dermatology OTC Medications Product Description
        11.1.5 Bayer Related Developments
    11.12 Lupin
        11.12.1 Lupin Corporation Information
        11.12.2 Lupin Overview
        11.12.3 Lupin Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.12.4 Lupin Product Description
        11.12.5 Lupin Related Developments
    11.13 Bausch Health
        11.13.1 Bausch Health Corporation Information
        11.13.2 Bausch Health Overview
        11.13.3 Bausch Health Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.13.4 Bausch Health Product Description
        11.13.5 Bausch Health Related Developments
    11.14 Cipla
        11.14.1 Cipla Corporation Information
        11.14.2 Cipla Overview
        11.14.3 Cipla Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.14.4 Cipla Product Description
        11.14.5 Cipla Related Developments
    11.15 Qilu Pharmaceutical
        11.15.1 Qilu Pharmaceutical Corporation Information
        11.15.2 Qilu Pharmaceutical Overview
        11.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.15.4 Qilu Pharmaceutical Product Description
        11.15.5 Qilu Pharmaceutical Related Developments
    11.16 Almirall
        11.16.1 Almirall Corporation Information
        11.16.2 Almirall Overview
        11.16.3 Almirall Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.16.4 Almirall Product Description
        11.16.5 Almirall Related Developments
    11.17 Lingrui
        11.17.1 Lingrui Corporation Information
        11.17.2 Lingrui Overview
        11.17.3 Lingrui Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.17.4 Lingrui Product Description
        11.17.5 Lingrui Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Dermatology OTC Medications Value Chain Analysis
    12.2 Dermatology OTC Medications Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Dermatology OTC Medications Production Mode & Process
    12.4 Dermatology OTC Medications Sales and Marketing
        12.4.1 Dermatology OTC Medications Sales Channels
        12.4.2 Dermatology OTC Medications Distributors
    12.5 Dermatology OTC Medications Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Dermatology OTC Medications Industry Trends
    13.2 Dermatology OTC Medications Market Drivers
    13.3 Dermatology OTC Medications Market Challenges
    13.4 Dermatology OTC Medications Market Restraints

14 Key Findings in The Global Dermatology OTC Medications Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer